Amgen GmbH · Munich Germany
Company Description
View Amgen GmbH Locations On A US Map
This link will open in a new window
This link will open in a new window Amgen GmbH speaks the language of biotech geeks, only with a German accent. Amgen GmbH is a German unit of US-based Amgen , the world's largest biotech company. The subsidiary was established in 1989 to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen and Aranesp, for the treatment of anemia in people with chronic kidney disease; Neupogen and Neulasta, to help restore white blood cell counts for cancer patients; and Enbrel, for the treatment of psoriasis and rheumatoid arthritis. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Amgen GmbH Financials
| Company Type | Subsidiary Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $25.6 |
| Employees | 67 |
Amgen GmbH Executives
7 executives listed for Amgen GmbH's Munich, location.
| Title | Name & Bio | Contact |
| EVP; Global Commercial Operations | George Morrow | Network |
| SVP; International Chief Medical Officer | Willard Dere | Network |
| SVP; International Commercial Operations | Rolf Hoffmann | Network |
Competition
Competitive Landscape for Amgen GmbH
Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is more than $350,000. Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery. To read the full description, subscribe now.Top Amgen GmbH Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!